Robert Perneczky
Overview
Explore the profile of Robert Perneczky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
231
Citations
4910
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurz C, Endres B, Hufnagel A, Tegethoff P, Perneczky R
MMW Fortschr Med
. 2025 Mar;
167(4):45-49.
PMID: 40050599
No abstract available.
2.
Volter F, Eckenweber S, Scheifele M, Eckenweber F, Hirsch F, Franzmeier N, et al.
Eur J Nucl Med Mol Imaging
. 2025 Feb;
PMID: 40019578
Purpose: Clinical staging in individuals with Alzheimer's disease (AD) typically relies on neuropsychological testing. Recognizing the imperative for an objective measure of clinical AD staging, regional perfusion in early-phase β-amyloid-PET...
3.
Alexopoulos P, Bountoulis C, Katirtzoglou E, Kosmidis M, Siarkos K, Yannakoulia M, et al.
Eur J Ageing
. 2025 Feb;
22(1):7.
PMID: 40000465
Depressive symptoms are common in mild cognitive impairment (MCI), dementia caused by Alzheimer's disease (AD dementia) and in cognitively unimpaired older adults. However, it is unclear whether they could contribute...
4.
Perneczky R, Darby D, Frisoni G, Hyde R, Iwatsubo T, Mummery C, et al.
J Prev Alzheimers Dis
. 2025 Feb;
:100096.
PMID: 39971671
Background: Many dementia and Alzheimer's disease (AD) registries operate at local or national levels without standardization or comprehensive real-world data (RWD) collection. This initiative sought to achieve consensus among experts...
5.
Haag L, Lancini E, Yakupov R, Ziegler G, Yi Y, Lusebrink F, et al.
Brain Commun
. 2025 Feb;
7(1):fcaf031.
PMID: 39926613
Neurotransmitter systems of noradrenaline, dopamine, serotonin and acetylcholine are implicated in cognitive functions such as memory, learning and attention and are known to be altered in neurodegenerative diseases like Alzheimer's...
6.
Schneider L, Freiesleben S, van Breukelen G, Wang X, Brosseron F, Heneka M, et al.
Alzheimers Dement
. 2025 Jan;
21(2):e14545.
PMID: 39868793
Introduction: The beneficial effects of amyloid beta 1-38, or Aβ(1-38), on Alzheimer's disease (AD) progression in humans in vivo remain controversial. We investigated AD patients' cerebrospinal fluid (CSF) Aβ(1-38) and...
7.
Roemer-Cassiano S, Wagner F, Evangelista L, Rauchmann B, Dehsarvi A, Steward A, et al.
Sci Transl Med
. 2025 Jan;
17(782):eadp2564.
PMID: 39841807
In Alzheimer's disease (AD), amyloid-β (Aβ) triggers the aggregation and spreading of tau pathology, which drives neurodegeneration and cognitive decline. However, the pathophysiological link between Aβ and tau remains unclear,...
8.
Lohner V, Perna L, Schottker B, Perneczky R, Brenner H, Mons U
Exp Gerontol
. 2025 Jan;
200:112684.
PMID: 39824235
Background: In light of growing evidence highlighting interactions between cardiac and brain health, we investigated associations of biomarkers of neurodegenerative diseases with adverse outcomes (all-cause and cardiovascular mortality, major cardiovascular...
9.
Liu K, Betts M, Hammerer D, Duzel E, Mather M, Roiser J, et al.
Brain Commun
. 2025 Jan;
7(1):fcae457.
PMID: 39801712
Hyperphosphorylated tau accumulation is seen in the noradrenergic locus coeruleus from the earliest stages of Alzheimer's disease onwards and has been associated with symptoms of agitation. It is hypothesized that...
10.
Bauer T, Brendel M, Zaganjori M, Bernhardt A, Bernhardt A, Jack A, et al.
Neuroimage
. 2025 Jan;
306():121001.
PMID: 39798829
Aim: Standardized evaluation of [F]PI-2620 tau-PET scans in 4R-tauopathies represents an unmet need in clinical practice. This study aims to investigate the effectiveness of visual evaluation of [F]PI-2620 images for...